The proof is in the pudding: patient engagement in studying cannabidiol in mild cognitive impairment

Abstract Background Patient engagement (PE) in clinical trials has gained importance yet remains uncommon, particularly in patients with mild cognitive impairment (MCI), a critical precursor to Alzheimer’s disease (AD). Cannabidiol (CBD) shows potential in slowing MCI progression due to its neuropro...

Full description

Bibliographic Details
Published in:	BMC Complementary Medicine and Therapies
Main Authors:	Antonia Keck, Julia-Sophia Scheuermann, Petra Scheerbaum, Elmar Graessel, Kirsten R. Müller-Vahl
Format:	Article
Language:	English
Published:	BMC 2025-01-01
Subjects:	Mild cognitive impairment Alzheimer’s disease Cannabidiol Cannabis-based medicine Patient engagement Patient and public involvement
Online Access:	https://doi.org/10.1186/s12906-025-04753-w

Similar Items

Individualised computerised cognitive training (iCCT) for community-dwelling people with mild cognitive impairment (MCI): results on cognition in the 6-month intervention period of a randomised controlled trial (MCI-CCT study)
by: Elmar Graessel, et al.
Published: (2024-10-01)

Disposition of Cannabidiol Metabolites in Serum and Urine from Healthy Individuals Treated with Pharmaceutical Preparations of Medical Cannabis
by: Ana Pilar Pérez-Acevedo, et al.
Published: (2020-12-01)

3D Printed Bigel: A Novel Delivery System for Cannabidiol-Rich Hemp Extract
by: Anna Gościniak, et al.
Published: (2024-11-01)

Cannabis Contaminants Limit Pharmacological Use of Cannabidiol
by: Zackary Montoya, et al.
Published: (2020-09-01)

Co-Dispersion Delivery Systems with Solubilizing Carriers Improving the Solubility and Permeability of Cannabinoids (Cannabidiol, Cannabidiolic Acid, and Cannabichromene) from <i>Cannabis sativa</i> (Henola Variety) Inflorescences
by: Anna Stasiłowicz-Krzemień, et al.
Published: (2023-09-01)

Cannabidiol use and perceptions in France: a national survey
by: Clémence Casanova, et al.
Published: (2022-08-01)

Patterns of cannabidiol use among marijuana users in the United States
by: Ji-Yeun Park
Published: (2025-02-01)

The Effects of Cannabidiol on the Driving Performance of Healthy Adults: A Pilot RCT
by: Toni Marie Rudisill, MS, PhD, et al.
Published: (2023-03-01)

When your patient asks about cannabidiol
by: Christopher Kudrich, et al.
Published: (2025-08-01)

Cannabidiol Content and In Vitro Biological Activities of Commercial Cannabidiol Oils and Hemp Seed Oils
by: Masashi Kitamura, et al.
Published: (2020-09-01)

Effects of Cannabidiol on Locomotor Activity
by: Fabrizio Calapai, et al.
Published: (2022-04-01)

A Balanced Approach for Cannabidiol Use in Chronic Pain
by: Donovan A. Argueta, et al.
Published: (2020-04-01)

Clinical and Cognitive Improvement Following Treatment with a Hemp-Derived, Full-Spectrum, High-Cannabidiol Product in Patients with Anxiety: An Open-Label Pilot Study
by: Rosemary T. Smith, et al.
Published: (2025-08-01)

Comparative Metabolomic Profiling of the Metabolic Differences of Δ9-Tetrahydrocannabinol and Cannabidiol
by: Qianru Rao, et al.
Published: (2022-11-01)

Current state of knowledge on the use of cannabidiol (CBD) in various medical conditions
by: Zuzanna Lubczyńska, et al.
Published: (2023-06-01)

Long‐term plasma monitoring of THC and CBD in pediatric drug‐resistant epilepsy: Implications for cannabidiol therapy with Epidyolex®
by: Alessia Cafaro, et al.
Published: (2025-10-01)

In Vitro Evidence of Selective Pro-Apoptotic Action of the Pure Cannabidiol and Cannabidiol-Rich Extract
by: Paweł Śledziński, et al.
Published: (2023-12-01)

Isolation, Purification, and Antimicrobial Characterization of Cannabidiolic Acid and Cannabidiol from <i>Cannabis sativa</i> L.
by: Laura Daniela Martinenghi, et al.
Published: (2020-06-01)

Pharmacokinetics behavior of four cannabidiol preparations following single oral administration in dogs
by: Sasithorn Limsuwan, et al.
Published: (2024-04-01)

Selling cannabidiol products in Canada: A framing analysis of advertising claims by online retailers
by: Marco Antonio Zenone, et al.
Published: (2021-07-01)

Cannabidiol as a Treatment for Chronic Pain: A Survey of Patients’ Perspectives and Attitudes
by: Schilling JM, et al.
Published: (2021-05-01)

Effects of Chronic Cannabidiol Treatment in the Rat Chronic Unpredictable Mild Stress Model of Depression
by: Zsolt Gáll, et al.
Published: (2020-05-01)

Disposition of Phytocannabinoids, Their Acidic Precursors and Their Metabolites in Biological Matrices of Healthy Individuals Treated with Vaporized Medical Cannabis
by: Francesco Paolo Busardò, et al.
Published: (2021-01-01)

Cannabis Effects on Driving Performance: Clinical Considerations
by: Brianna Costales, et al.
Published: (2023-01-01)

Acceptability of and attitudes to the therapeutic use of cannabis and cannabidiol in people with Parkinson’s disease: A French survey
by: Tangui Barré, et al.
Published: (2024-01-01)

Combinations of Cannabidiol and Δ<sup>9</sup>-Tetrahydrocannabinol in Reducing Chemotherapeutic Induced Neuropathic Pain
by: Diana E. Sepulveda, et al.
Published: (2022-10-01)

Production of Cannabidiol Acid Synthase by Chassis Pichia pastoris and of Its Catalytic Activity Analysis
by: Tingli NIU, et al.
Published: (2023-10-01)

A phase III multisite randomised controlled trial to compare the efficacy of cannabidiol to placebo in the treatment of cannabis use disorder: the CBD-CUD study protocol
by: Anjali K. Bhardwaj, et al.
Published: (2024-03-01)

The Potential of Cannabidiol for Treating Canine Atopic Dermatitis
by: Ana F. Bizarro, et al.
Published: (2025-02-01)

The Influence of Cannabidiol on the Pharmacokinetics of Methylphenidate in Healthy Subjects
by: John S. Markowitz, et al.
Published: (2022-11-01)

Safety assessment of female sexual hygiene product containing cannabidiol in new zealand white rabbit and clinical trial
by: Atiwut Kamudhamas, et al.
Published: (2024-12-01)

Anthocyanin accumulation, inflorescence dry weight and total cannabidiol content have different temperature optima in Cannabis sativa
by: Sean R. Kim, et al.
Published: (2025-07-01)

Translational Investigation of the Therapeutic Potential of Cannabidiol (CBD): Toward a New Age
by: José A. Crippa, et al.
Published: (2018-09-01)

Evaluation of the Analgesic Effect of High-Cannabidiol-Content Cannabis Extracts in Different Pain Models by Using Polymeric Micelles as Vehicles
by: Yoreny Román-Vargas, et al.
Published: (2023-05-01)

Cannabidiol Exposure During the Mouse Adolescent Period Is Without Harmful Behavioral Effects on Locomotor Activity, Anxiety, and Spatial Memory
by: J. S. Kaplan, et al.
Published: (2021-08-01)

The protocol for the Cannabidiol in children with refractory epileptic encephalopathy (CARE-E) study: a phase 1 dosage escalation study
by: Darren Reithmeier, et al.
Published: (2018-07-01)

Mechanisms of Cannabidiol (CBD) in Cancer Treatment: A Review
by: Camren G. Heider, et al.
Published: (2022-05-01)

Cure-All cannabidiol? The cannabidiol content of commercial products
by: Michaela Mouton, et al.
Published: (2024-02-01)

From an Alternative Medicine to a New Treatment for Refractory Epilepsies: Can Cannabidiol Follow the Same Path to Treat Neuropsychiatric Disorders?
by: Rafael M. Bitencourt, et al.
Published: (2021-02-01)

Cannabidiol-Loaded Nanocarriers and Their Therapeutic Applications
by: Elham Assadpour, et al.
Published: (2023-03-01)